Literature DB >> 18063126

National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006.

William R Jarvis1, JoAnn Schlosser, Raymond Y Chinn, Samantha Tweeten, Marguerite Jackson.   

Abstract

BACKGROUND: Despite methicillin-resistant Staphylococcus aureus (MRSA) being endemic in virtually all US health care facilities, there are no data on the prevalence of MRSA in US health care facilities.
METHODS: We conducted a national prevalence survey of MRSA in inpatients at US health care facilities. The survey was developed, received institutional review board approval, and then distributed to all members of the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC). Members were asked to complete the survey on one day during the period October 1 to November 16, 2006, reporting the number of inpatients with MRSA infection or colonization and facility-specific information.
RESULTS: Personnel at 1237 hospitals completed the survey. Complete facility data were provided for 1187 (96%) of these health care facilities. All states were represented (mean, 23 facilities per state; range, 1-99). Respondents reported 8654 MRSA-colonized/infected patients in 187,058 inpatients; the overall MRSA prevalence rate was 46.3 per 1000 inpatients (34 infections and 12 colonizations per 1000 inpatients). Active MRSA surveillance testing was conducted by 29% of respondents: 54% used routine media, 38% used selective media, and 8% used polymerase chain reaction. Detailed data were provided on 7994 (92.4%) MRSA-colonized/infected patients. Our data suggest that approximately 70% of isolates were more consistent with health care-associated MRSA (HA-MRSA) than community-associated MRSA.
CONCLUSION: Our survey documents a much higher MRSA prevalence rate than previous studies using different methodologies. The majority of MRSA in inpatients appears to be HA-MRSA. Given that most facilities did not perform active surveillance testing, these are minimum estimates of the national burden of MRSA in US health care facilities.

Entities:  

Mesh:

Year:  2007        PMID: 18063126     DOI: 10.1016/j.ajic.2007.10.009

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  38 in total

1.  A report on the first case of vancomycin-intermediate Staphylococcus aureus (VISA) in Hawai'i.

Authors:  Suttirak Chaiwongkarjohn; Pornpoj Pramyothin; Nuntra Suwantarat; Matthew J Bankowski; Terrie Koyamatsu; Steven E Seifried; Erlaine F Bello
Journal:  Hawaii Med J       Date:  2011-11

2.  MRSA: The Private-Sector Response.

Authors:  Virginia Jackson; David B Nash
Journal:  Biotechnol Healthc       Date:  2008-05

3.  Quantifying interhospital patient sharing as a mechanism for infectious disease spread.

Authors:  Susan S Huang; Taliser R Avery; Yeohan Song; Kristen R Elkins; Christopher C Nguyen; Sandra K Nutter; Alaka A Nafday; Curtis J Condon; Michael T Chang; David Chrest; John Boos; Georgiy Bobashev; William Wheaton; Steven A Frank; Richard Platt; Marc Lipsitch; Robin M Bush; Stephen Eubank; Donald S Burke; Bruce Y Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

4.  Infection control and prevention: a review of hospital-acquired infections and the economic implications.

Authors:  Deoine Reed; Sandra A Kemmerly
Journal:  Ochsner J       Date:  2009

5.  The effect of co-colonization with community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus strains on competitive exclusion.

Authors:  Joanna Pressley; Erika M C D'Agata; Glenn F Webb
Journal:  J Theor Biol       Date:  2010-03-27       Impact factor: 2.691

Review 6.  Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.

Authors:  Jesús López-Alcalde; Marta Mateos-Mazón; Marcela Guevara; Lucieni O Conterno; Ivan Solà; Sheila Cabir Nunes; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

7.  Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?

Authors:  Elizabeth Mostofsky; Marc Lipsitch; Gili Regev-Yochay
Journal:  J Antimicrob Chemother       Date:  2011-07-07       Impact factor: 5.790

8.  Certification in infection control matters: Impact of infection control department characteristics and policies on rates of multidrug-resistant infections.

Authors:  Monika Pogorzelska; Patricia W Stone; Elaine L Larson
Journal:  Am J Infect Control       Date:  2012-03       Impact factor: 2.918

Review 9.  Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?

Authors:  Georgia R Sampedro; Juliane Bubeck Wardenburg
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

10.  Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics.

Authors:  Adriel Villegas-Estrada; Mijoon Lee; Dusan Hesek; Sergei B Vakulenko; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2008-06-27       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.